Literature DB >> 32075771

A Two-Layered Targeting Mechanism Underlies Nuclear RNA Sorting by the Human Exosome.

Guifen Wu1, Manfred Schmid1, Leonor Rib2, Patrik Polak1, Nicola Meola1, Albin Sandelin2, Torben Heick Jensen3.   

Abstract

Degradation of transcripts in human nuclei is primarily facilitated by the RNA exosome. To obtain substrate specificity, the exosome is aided by adaptors; in the nucleoplasm, those adaptors are the nuclear exosome-targeting (NEXT) complex and the poly(A) (pA) exosome-targeting (PAXT) connection. How these adaptors guide exosome targeting remains enigmatic. Employing high-resolution 3' end sequencing, we demonstrate that NEXT substrates arise from heterogenous and predominantly pA- 3' ends often covering kilobase-wide genomic regions. In contrast, PAXT targets harbor well-defined pA+ 3' ends defined by canonical pA site use. Irrespective of this clear division, NEXT and PAXT act redundantly in two ways: (1) regional redundancy, where the majority of exosome-targeted transcription units produce NEXT- and PAXT-sensitive RNA isoforms, and (2) isoform redundancy, where the PAXT connection ensures fail-safe decay of post-transcriptionally polyadenylated NEXT targets. In conjunction, this provides a two-layered targeting mechanism for efficient nuclear sorting of the human transcriptome.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3′ end sequencing; NEXT complex; PAXT connection; nuclear RNA turnover; pA(+)/pA(−) RNA

Mesh:

Substances:

Year:  2020        PMID: 32075771     DOI: 10.1016/j.celrep.2020.01.068

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.995


  17 in total

1.  The RNA exosome shapes the expression of key protein-coding genes.

Authors:  Mengjun Wu; Evdoxia Karadoulama; Marta Lloret-Llinares; Jerome Olivier Rouviere; Christian Skov Vaagensø; Martin Moravec; Bingnan Li; Jingwen Wang; Guifen Wu; Maria Gockert; Vicent Pelechano; Torben Heick Jensen; Albin Sandelin
Journal:  Nucleic Acids Res       Date:  2020-09-04       Impact factor: 16.971

2.  Conserved DNA sequence features underlie pervasive RNA polymerase pausing.

Authors:  Martyna Gajos; Olga Jasnovidova; Alena van Bömmel; Susanne Freier; Martin Vingron; Andreas Mayer
Journal:  Nucleic Acids Res       Date:  2021-05-07       Impact factor: 16.971

3.  Regulation of human telomerase RNA biogenesis and localization.

Authors:  Jian Qin; Chantal Autexier
Journal:  RNA Biol       Date:  2020-09-02       Impact factor: 4.652

4.  Structural basis for RNA surveillance by the human nuclear exosome targeting (NEXT) complex.

Authors:  M Rhyan Puno; Christopher D Lima
Journal:  Cell       Date:  2022-06-09       Impact factor: 66.850

5.  Internal oligo(dT) priming introduces systematic bias in bulk and single-cell RNA sequencing count data.

Authors:  Marek Svoboda; H Robert Frost; Giovanni Bosco
Journal:  NAR Genom Bioinform       Date:  2022-05-25

6.  Modeling Pathogenic Variants in the RNA Exosome.

Authors:  Julia de Amorim; Anne Slavotinek; Milo B Fasken; Anita H Corbett; Derrick J Morton
Journal:  RNA Dis       Date:  2020

Review 7.  RNA helicases are hubs that orchestrate exosome-dependent 3'-5' decay.

Authors:  Eva-Maria Weick; Christopher D Lima
Journal:  Curr Opin Struct Biol       Date:  2020-11-02       Impact factor: 6.809

8.  Identification of nucleotide sequences and some proteins involved in polyadenylation of RNA transcribed by Pol III from SINEs.

Authors:  Ilia G Ustyantsev; Olga R Borodulina; Dmitri A Kramerov
Journal:  RNA Biol       Date:  2020-12-11       Impact factor: 4.652

9.  The zinc-finger protein Red1 orchestrates MTREC submodules and binds the Mtl1 helicase arch domain.

Authors:  Nikolay Dobrev; Yasar Luqman Ahmed; Anusree Sivadas; Komal Soni; Tamás Fischer; Irmgard Sinning
Journal:  Nat Commun       Date:  2021-06-08       Impact factor: 14.919

Review 10.  Nuclear RNA Exosome and Pervasive Transcription: Dual Sculptors of Genome Function.

Authors:  Koichi Ogami; Hiroshi I Suzuki
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.